Susie Jones
About
In The Last Decade
Susie Jones
19 papers receiving 868 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 412
- Oncology 326
- Cancer Research 174
- Physiology 164
- Pulmonary and Respiratory Medicine 111
Countries citing papers authored by Susie Jones
This map shows the geographic impact of Susie Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susie Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susie Jones more than expected).
Fields of papers citing papers by Susie Jones
This network shows the impact of papers produced by Susie Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susie Jones. The network helps show where Susie Jones may publish in the future.
Co-authorship network of co-authors of Susie Jones
This figure shows the co-authorship network connecting the top 25 collaborators of Susie Jones. A scholar is included among the top collaborators of Susie Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susie Jones. Susie Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 9 | |
| 3 | 33 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 20 | |
| 7 | 54 | |
| 8 | 313 | |
| 9 | 89 | |
| 10 | 24 | |
| 11 | 1 | |
| 12 | 85 | |
| 13 | The Way that PEGyl-DSPC Liposomal Doxorubicin Particles Penetrate into Solid Tumor Tissue. | 2 |
| 14 | 1 | |
| 15 | 5 | |
| 16 | 157 | |
| 17 | 24 | |
| 18 | 50 | |
| 19 | Excessive use of inhaled salbutamol: the potential benefits of dose-reduction. A case report. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.